General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Objective long/short (AUPH) Report | news.google.com • |
Aurinia Pharmaceuticals (NASDAQ:AUPH) Shares Up 6.2% | news.google.com • |
New York State Common Retirement Fund Has $438000 Stock Holdings in Aurinia Pharmaceuticals Inc. (NASDAQ ... | news.google.com • |
Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss, Misses Revenue Estimates | news.google.com • |
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Short Interest Down 9.9% in April | news.google.com • |
Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock Crosses Below 200 Day Moving Average of $6.98 | news.google.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-02 | 2024-03 | -0.17 | -0.03 | 0.14 | 82.35% |
2024-02-15 | 2023-12 | -0.18 | -0.19 | -0.01 | -5.56% |
2023-11-02 | 2023-09 | -0.17 | -0.09 | 0.08 | 47.06% |
2023-08-03 | 2023-06 | -0.2 | -0.08 | 0.12 | 60.00% |
2023-05-04 | 2023-03 | -0.24 | -0.18 | 0.06 | 25.00% |
2023-02-28 | 2022-12 | -0.26 | -0.18 | 0.08 | 30.77% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-09-21 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-08-06 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-07-05 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-05-02 | HC Wainwright & Co. | Upgrade | Buy | |
2023-02-22 | RBC Capital | Upgrade | Outperform | |
2023-01-03 | RBC Capital | Upgrade | Outperform |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2023-05-22 | BILLEN DANIEL | Director | 33.39K | Sale |
2024-03-05 | DONLEY MATTHEW MAXWELL | Officer | 584.07K | Sale |
2024-03-05 | GREENLEAF PETER S | Chief Executive Officer | 1.52M | Sale |
2024-03-05 | HABIG SCOTT MICHAEL | Officer | 474.59K | Sale |
2023-05-22 | JAYNE DAVID ROLAND WALKER | Director | 49.31K | Sale |
2024-02-26 | KNAPPERTZ VOLKER | Officer | 319.13K | Sale |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Blackrock Inc. | 8.33M | 80.66M | 5.81% |
2023-06-29 | Armistice Capital, LLC | 4.69M | 45.42M | 3.27% |
2023-06-29 | NEA Management Company, LLC | 3.97M | 38.43M | 2.77% |
2023-06-29 | State Street Corporation | 2.63M | 25.48M | 1.84% |
2023-06-29 | Goldman Sachs Group Inc | 1.74M | 16.88M | 1.22% |
2023-06-29 | Morgan Stanley | 1.69M | 16.32M | 1.18% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-08-30 | iShares Russell 2000 ETF | 3.09M | 28.03M | 2.15% |
2023-07-30 | Fidelity Small Cap Index Fund | 1.21M | 13.98M | 0.84% |
2023-08-30 | iShares Russell 2000 Growth ETF | 1.13M | 10.28M | 0.79% |
2023-06-29 | College Retirement Equities Fund-Stock Account | 1.10M | 10.67M | 0.77% |
2023-08-30 | iShares NASDAQ Biotechnology ETF | 921.41K | 8.36M | 0.64% |
2023-07-30 | TIAA-CREF Funds-Quant Small Cap Equity Fund | 755.87K | 8.75M | 0.53% |
Might sound odd to many, but I’m thankful for the 17% pullback we’ve seen over the last week! I know we all want an immediate buyout and were hopeful with the JPM Conference… but we all know that this price is CHEAP and we likely won’t get too many more opportunities to buy at these levels… It’s not too often you get to buy a de-risked company that has has this level of revenue growth, product gross margin of 96%, and the possibility of a BO in the near foreseeable future… however, knowing the history and volatility, I’m loading up when I can and with a total share qty I’m comfortable with if this and taking opportunities to trim high cost share when available. GLTA!
Regardless of buyout or not, the chart is clearly breaking out.
$AUPH sign the deal PiG or get voted out next round of greedy undeserved options you think you have earned
AUPH let’s get this deal signed before your voted out the door PiG
I have the same issue